University Hospitals (UH) Seidman Cancer Center in Ohio, US, has joined the Caris Precision Oncology Alliance (POA), a network of cancer centres and research consortia that collaborate to advance precision oncology and biomarker-driven research.
The alliance allows its members to leverage Caris’ clinico-genomic database, with an aim to help boost cancer patients’ clinical outcomes.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It comprises 87 cancer centres, academic institutions, research consortia and healthcare systems.
UH Seidman Cancer Center president and scientific director Theodoros Teknos said: “The collective power wrought by combining artificial intelligence (AI) with the brightest oncologic minds and the most extensive cancer profiling database is sure to lead to breakthroughs in cancer care.
“The academic faculty at University Hospitals Seidman Cancer Center are thrilled to join forces with the Caris Precision Oncology Alliance.
“This collaborative effort solidifies our reputation as one of the leading cancer research institutions in the world.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataUH Seidman is claimed to be the only freestanding cancer hospital in Northeast Ohio and is part of the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center at Case Western Reserve University.
The addition of UH Seidman to the alliance is considered a significant step forward in the fight against cancer.
POA chairman Chadi Nabhan said: “The researchers, clinicians, and leaders of Seidman Cancer Center share the same vision of the Caris Precision Oncology Alliance, to improve the outcomes of all patients diagnosed with cancer through cutting-edge precision oncology research.”
